58 results about "Bone health" patented technology

The invention belongs to the technical field of microbial fermentation, and particularly relates to lactobacillus rhamnosus capable of maintaining bone health and improving local joint inflammation and a metagen and application of the lactobacillus rhamnosus. According to the invention, the probiotic NKU ML1-2 is subjected to fermentation culture, such that a post-generation product is prepared. Results of embodiments prove that the metagen product can enhance the oxidation resistance of cartilage and osteoblasts and promote the synthesis of anti-inflammatory factors and cartilage matrixes (type II collagen and proteoglycan), and has the potential of relieving oxidative stress and inflammatory response of local joints, relieving joint inflammation and delaying cartilage destruction. The prepared metagen product is high in safety and good in stability, and can be applied to preparation of medicines for preventing and / or treating osteoarthritis; the metagen product can also be used for promoting bone health, enhancing the antioxidant capacity of osteoblasts and / or chondrocytes, promoting osteoblast activity and / or promoting calcium absorption and fixation, and a new solution is provided for joint health management.

The invention belongs to the technical field of biological medicine, and discloses a probiotic agent capable of improving the physiological activity function of vitamin D and maintaining bone health and application of the probiotic agent. The invention provides a probiotic agent composed of bifidobacterium adolescentis and bifidobacterium longum, the probiotic agent can significantly improve the bone mineral density, the bone trabecula thickness, the bone trabecula number, the bone trabecula connectivity and the bone volume fraction of an osteoporosis mouse, and meanwhile, the bone trabecula separation degree of the osteoporosis-removed mouse is significantly reduced; the level of vitamin D metabolites such as 25-hydroxy vitamin D and 1, 25-dihydroxy vitamin D in mouse serum is improved; the content of serum calcium and alkaline phosphatase in serum of mice is reduced, and the level of osteocalcin and type I procollagen amino terminal peptide in the serum is improved. The probiotic agent can relieve bone calcium loss, maintain bone health, repair bone injury, increase osteoblasts and reduce the osteoporosis degree, and can be used for preparing drugs for preventing and / or treating osteoporosis or preparing health care products or food beneficial to improving bone mineral density.

The embodiment of the invention discloses a skeleton health dynamic tracking and intervention method and system based on movement and nutrition. The method comprises the following steps: acquiring gait information, bone metabolite information and bone state measurement parameters of a target user by adopting wearable equipment; processing the gait information, the bone metabolite information and the bone state measurement parameters based on an artificial intelligence (AI) model to obtain bone state prediction parameters; according to the bone state prediction parameter and the health data of the target user, performing bone health state evaluation of the target user to obtain a health state prediction parameter; the health state prediction parameters comprise a bone health state instant evaluation index and bone health dynamic trend data; generating a targeted exercise plan and a diet plan according to the health state prediction parameters; wherein the target motion planning is used for guiding the motion of the target user; the diet planning is used for guiding the diet of the target user.

The invention discloses a lactobacillus rhamnosus capable of improving joint inflammation and promoting bone health, a metagen and application of the lactobacillus rhamnosus, the lactobacillus rhamnosus is lactobacillus rhamnosus BN02, the lactobacillus rhamnosus is preserved in China General Microbiological Culture Collection Center on November 27, 2023, and the preservation number is CGMCC No.29133. The lactobacillus rhamnosus can be used for improving joint inflammation and promoting bone health. The lactobacillus rhamnosus BN02 can reduce the number of gram-negative bacteria in intestinal tracts of arthritis patients, increase the synthesis amount of bone collagen, and is beneficial to promoting absorption of vitamin C by the intestinal tracts, improving joint inflammation and promoting bone health.

The invention relates to the technical field of medical information, in particular to an osteoporosis risk intelligent early warning method and system based on a big database. The method comprises the following steps: extracting user bone health data in a multi-source health database; evaluating a bone mass state based on the user bone health data; screening osteoporosis risk users in the user bone health data according to the bone mass state; inquiring a medical image of the osteoporosis risk user; extracting a bone mineral density value by using the medical image, and determining a bone mineral density change trend according to the bone mineral density value; detecting the degeneration degree of the bone microstructure by using a medical image; constructing an osteoporosis risk early warning model according to the bone mineral density change trend and the bone microstructure degeneration degree; and inputting the user bone health data into the osteoporosis risk early warning model to generate a risk early warning score. According to the invention, accurate identification and dynamic monitoring of the osteoporosis risk user are realized based on the medical information technology, and the accuracy and response rate of osteoporosis risk early warning are improved.

The invention relates to an application of plant lactobacillus Hi188 in promotion of bone health. The invention provides the application of the plant lactobacillus Hi188 or the afterbiogen thereof or the composition thereof in increasing the bone mineral density, increasing the bone mineral density, promoting the skeletal development, increasing the bone mineral content and / or promoting the tibia growth. Or preparing food for increasing bone mineral density, increasing bone mineral density, promoting skeletal development, increasing bone mineral content and / or promoting tibia growth; wherein the composition comprises: (A) Phytobacterium plantarum Hi188 or a postbiotic thereof, and (B) Bifidobacterium lactis Ca360 or a postbiotic thereof.

The application discloses a functional composition for improving bone and joint health, a conditioner and application. The functional composition comprises a first active component and a second active component; the first active component comprises elastin peptide, haematococcus pluvialis and ergothioneine; and the second active component comprises one or more of houttuynia cordata and non-denatured type II collagen. The application realizes the protection effect on joint, cartilage and bone health by scientific matching of the components and synergistically improving the glycosaminoglycan level in chondrocytes and the osteocalcin level in osteoblasts. Meanwhile, the components in the functional composition for improving bone and joint health are natural and have good biocompatibility, and have no obvious side effects, so that the application provides a kind of drug or a substitute for the treatment and prevention of bone diseases.

The application discloses a multi-source bone density data fusion method, system and storage medium, and belongs to the field of medical big data and intelligent diagnosis. The method aims at the systematic deviation between DXA devices of different manufacturers and the high detection uncertainty problem under the primary medical environment. Firstly, the multi-source bone density data and the corresponding physical calibration parameters are projected to a unified measurement space through standardized preprocessing and device-related mapping functions, and the device barriers are eliminated by using distribution alignment constraints. Then, Gaussian uncertainty modeling is performed on the projected data to quantify the influence of specific clinical factors on measurement reliability. Based on the uncertainty propagation mechanism, the multi-source discrete evidence is adaptively compensated and fused by weight, and multi-dimensional features including physiology, medical history and anatomical topology are introduced for joint modeling. Finally, end-to-end optimization is performed through a joint function of fusion uncertainty constraint and task loss, and high-robustness osteoporosis risk intelligent evaluation is realized. The application significantly improves the consistency of cross-device T value prediction and the accuracy of missed diagnosis / misdiagnosis review, and is suitable for multi-center bone density mutual recognition and primary medical bone health intelligent evaluation scene.

The present invention discloses a measurement and judgment method for orthopedic diagnosis, which belongs to the technical field of orthopedic diagnosis and treatment, comprising: collecting magnetic field signals of bone metabolism through a magnetic field sensor array, collecting electrical impedance spectroscopy data through a four-electrode method to form an original data set; filtering and denoising the magnetic field signals and correcting motion artifacts, and then fitting the electrical impedance spectroscopy data with a Cole-Cole model to extract bone density, porosity, and moisture content; calculating bone metabolic current density through a magnetic field-current inversion algorithm, combining electrical impedance characteristics and current characteristics, and generating a bone health index through a dynamic weight distribution mechanism; by combining the magnetic field-current inversion algorithm with Cole-Cole model analysis, multi-dimensional information of bone metabolic activity and bone tissue structure can be simultaneously obtained, thereby effectively overcoming the problem of insufficient information from a single physical field and significantly improving the accuracy of diagnosis.

A method and system for analysis of medical images is presented in the field of analysis of medical images. The method and systems is provided to determine one or more parameters of bones in medical images. The method and system may be characterized as an advancement in analysis of medical images to ascertain bone health and discern pathologies in bone. Specifically, a system and method is disclosed for analysing medical images showing at least a portion of a bone to determine one or more bone parameters for the at least one portion of a bone. Steps taken by the system and method include: determining a region of interest of the medical image; identifying a boundary of at least one of an inner edge and an outer edge of cortical bone of the at least one portion of the bone within the region of interest; identifying at least one boundary of trabecular bone of the at least one portion of the bone within the region of interest; utilising the identified boundaries to determine at least one of the following bone parameters: orientation, bone mineral density, length, width of trabecular structure, for the at least one portion of bone within the region of interest.

The application discloses a composition for improving bone density and application thereof, and belongs to the technical field of food. The composition is prepared by using 1,3-dioleic acid-2-palmitic acid triglyceride, osteonectin and oligosaccharide in combination, and through the interaction between the components, the absorption and utilization of each other are promoted, the growth and development of the bone of an infant in the growth period are improved, the bone mineral content and bone density are improved, the bone health is promoted, and the composition is safe and has no side effect. Through optimization of the types of the oligosaccharide, it is found that the combination of oligogalactose and 2'-fucosyllactose can better improve the growth and development of the bone of the infant in the growth period.

The invention provides a bone evaluation method based on neural network enhancement and finite element analysis. The bone evaluation method comprises the following steps: acquiring an ultrahigh-resolution CT image of a living vertebra; performing domain conversion processing on the CT image by adopting a generative neural network; carrying out resampling and segmentation on the enhanced CT image; constructing a bone trabecula microstructure model in the cancellous bone mask area; assembling the RVE unit and the cortical bone model into a complete vertebral finite element model, and applying a multi-working-condition load to the RVE unit to calculate anisotropic material parameters; and carrying out axial compression finite element analysis on the complete centrum model, and judging the bone health state. According to the method, information of two dimensions of bone mass and bone, especially contribution of a bone trabecula microstructure to bone strength, is comprehensively considered, bone degeneration and fracture high-risk patients can be recognized earlier, and a scientific basis is provided for clinical early intervention.

Described herein are compositions for maintaining and / or improving bone health in a subject (e.g., an aging subject) comprising N 1 - dihydrocaffeoyl-N 10 - caffeoyl spermidine and an additive. Further, described herein are methods for maintaining and / or improving bone health in a subject (e.g., an aging subject). Further, described herein are methods for preventing and / or treating bone disease in a subject (e.g., an aging subject).

The present invention relates to the use of a composition comprising an effective amount of a combination of fesoterodine and / or a derivative thereof and quercetin and / or a derivative for preventing or treating a bone disorder or maintaining bone health in an individual.

The invention discloses a functional composition capable of improving bone and joint health, a conditioner and application. The functional composition comprises a first active component and a second active component, the first active component is prepared from elastin peptide, haematococcus pluvialis and ergothioneine; the second active component is prepared from one or more of herba houttuyniae and non-denatured type II collagen. Through scientific compatibility of all the components, the levels of glycosaminoglycan in chondrocytes and osteocalcin in osteoblasts are synergistically improved, and the protection effect on joint, cartilage and skeleton health is achieved. Meanwhile, a plurality of components in the functional composition capable of improving the health of the bones and the joints are natural in source, good in biocompatibility and free of obvious side effects, and a medicine or an alternative scheme thereof is provided for treatment and prevention of the bone diseases.

The application belongs to the technical field of biology and specifically relates to a casein phosphopeptide for promoting calcium, iron and zinc mineral absorption and improving bone health. The application obtains the casein phosphopeptide containing high-activity peptide segments by optimizing the process, and takes six mineral elements of calcium, magnesium, copper, iron, zinc and manganese as research objects. Firstly, the mineral deficiency rat model is used to evaluate the mineral utilization of the CPP. The consumption of 7mg / kg.d increases the contents of Ca, Mg, Cu, Fe, Zn and Mn in femur by 7.12%, 3.56%, 20.76%, 15.84%, 9.94% and 67.12% respectively. Secondly, the molecular docking technology is used to screen the peptide segments with calcium absorption activity from the CPP and perform function verification. The application aims to reveal the effect of the CPP in the mineral absorption and utilization from the cell and animal levels, and provide a theoretical basis for the functional development.

This utility model discloses a quantitative dispensing container for formulated milk powder for bone health in middle-aged and elderly people. It includes a mixing tank, a cover plate fixedly installed on the top of the mixing tank, an outer shell fixedly installed on the top of the cover plate, and a mounting plate rotatably connected to the inner top of the outer shell. A discharge pipe is fixedly installed on the left end of the top of the cover plate, and a baffle is sleeved and connected to the outside of the discharge pipe. A rotating component is located at the middle position of the top of the cover plate, and an adjusting component is located on the left end of the top of the cover plate. The discharge component is mounted on the mounting plate. This quantitative dispensing container for formulated milk powder for bone health in middle-aged and elderly people can effectively control the intake through the rotation of the discharge baffle, reducing the risk of insufficient or excessive intake, thereby ensuring the acquisition of appropriate nutrients. Furthermore, the shielding of the lower end of the hopper effectively prevents the milk from contacting air and also effectively prevents accidental powder leakage or splashing.

This invention discloses a composition with bone-health-promoting functions and its applications, belonging to the field of microbial engineering. The composition comprises milk calcium, colostrum basic protein, and Bifidobacterium breve i1088 powder. The composition provided by this invention, which has a synergistic effect between milk calcium, colostrum basic protein, and Bifidobacterium breve i1088 powder, enhances the conversion rate of calcium from the blood to bone through the action of probiotics, thereby improving the actual utilization rate of calcium and effectively promoting bone health. Experimental data show that this composition significantly increases bone mineral density, bone volume fraction, and trabecular thickness in a female rat osteoporosis model, and significantly reduces trabecular spacing in the same model. The composition provided by this invention is suitable for promoting bone health and preventing and / or improving osteoporosis.

The application provides a composition for promoting bone health and bone formation, and application and products thereof, and belongs to the field of food. The composition of the application is composed of 2'-fucosyllactose, osteopontin and a calcium source, wherein the osteopontin is 1-5 parts, the 2'-fucosyllactose is 1-50 parts and the calcium source is 0.05-50 parts by weight. The composition of the application shows a good synergistic effect in promoting calcium absorption, and can be used for increasing bone density, preventing and treating osteoporosis and the like.

The invention discloses a traditional Chinese medicine composition helpful for improving bone mineral density and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 3-5 parts of folium cortex eucommiae, 1-3 parts of herba cistanche, 1-2 parts of rhizoma polygonati and 1-2 parts of semen persicae. The traditional Chinese medicine composition has the safety of food materials and the conditioning effect of medicinal materials, avoids the side effects of gastrointestinal stimulation, metabolic disorder and the like possibly caused by chemical preparations, and is suitable for being taken for a long time to maintain bone health.

The invention relates to application of Shengui blood-nourishing oral liquid in promoting development and growth, and the Shengui blood-nourishing oral liquid promotes development and growth by activating related growth factors, remarkably enhancing bone health and improving bone density and bone growth speed.

The invention provides a bone health assessment and fracture risk prediction system based on a cross-scale mechanical model, and the system comprises a data obtaining unit which is used for obtaining clinical image data of a user and user information data; the data processing unit is used for performing multi-scale feature extraction on the clinical image data to obtain macroscopic geometric morphology features, density distribution features, regional scale features and texture scale features of the skeleton; the mechanical response parameter calculation unit is used for calculating mechanical response parameters of the skeleton under various load working conditions on the basis of the user information data, a preset skeleton template library and macroscopic geometrical morphology characteristics and density distribution characteristics of the skeleton; and the integrated risk assessment unit is used for determining the fracture risk probability based on the regional scale features, the texture scale features and the mechanical response parameters. According to the invention, the accuracy and comprehensiveness of fracture risk assessment can be improved.

The invention relates to the technical field of health risk assessment, in particular to a postmenopausal osteoporosis risk prediction and traditional Chinese and western medicine intervention management system. The system quantifies the trend risk of the bone mineral density through the deviation change of the bone mineral density risk value in time sequence, and combines the initial bone mineral density risk to divide the group and analyze and identify the risk degree of the group; coupling the drop fluctuation characteristics of hormones with the change of bone metabolism markers to obtain the comprehensive metabolic risk influence degree; determining the comprehensive influence degree of osteoporosis by utilizing the group comprehensive bone mineral density risk degree dynamic adjustment and combining the external risk influence degree and the comprehensive metabolic risk influence degree; and based on the osteoporosis comprehensive influence degree of the sample data, training a neural network model to carry out risk prediction. According to the method, the risk model is constructed by considering the multi-dimensional influence of hormone metabolism and behavioral habits of the postmenopausal patient and the multi-dimensional coupling evaluation value, so that the risk prediction accuracy is improved, and more comprehensive and reliable data support is provided for bone health management of postmenopausal women.

The invention provides an old people bone health data extraction method and system based on a lifting method, and relates to the field of intelligent medical treatment, and the method comprises the steps: carrying out the preprocessing, feature coarse screening and dynamic selection of multi-modal medical data, obtaining an optimal feature set, carrying out the retraining of an XGBoost multi-classification model through the optimal feature set, outputting a risk probability vector, and carrying out the recognition of the risk probability vector. Recognizing a low-confidence sample, correcting the risk level classification of the low-confidence sample by using a double-model collaborative optimization strategy, and finally analyzing a model decision mechanism by using a TreeSHAP algorithm to generate a multi-modal interpretable report. Statistical screening and machine learning evaluation are fused, high-dimensional feature self-adaptive compression is achieved, limitation of a traditional single index on dimension control and interactive recognition is broken through, model stability and prediction accuracy are improved, meanwhile, model interpretability is enhanced through SHAP visualization, and credible auxiliary reference is provided for clinical treatment.

This application discloses a composition, conditioning agent, and application for protecting bone health. The active ingredients of the composition for protecting bone health include purslane powder, cucumber powder, celery powder, and Solomon's seal powder. This application scientifically combines the four active ingredients to fully leverage their synergistic effects, effectively activating the Runx2 gene and its expression, promoting the production of bone matrix proteins, and significantly intervening in and improving bone discomfort caused by bone matrix protein deficiency. Furthermore, the composition uses naturally derived active ingredients, exhibiting high safety, excellent biocompatibility, and no obvious side effects. The good compatibility between the active ingredients allows for preparation into various dosage forms according to actual needs, making application convenient and with high compliance. Thus, this provides an effective functional active composition for protecting bone health.

A method is for correcting a concentration of a bone turnover marker to obtain an adjusted value which gives an indication of an individual's bone health status or amount of changes occurred over time or by treatment while eliminating the influence of possible pre-analytical variability. The method includes: obtaining the concentration of the bone turnover marker of a sample; correcting the obtained concentration using a mathematical model which comprises at least three factors, different from the bone health status, such that for the adjusted value variabilities in the concentration of the bone turnover marker, that are caused by the at least three factors, are substantially filtered out by the mathematical model.

Methods and compositions for promoting bone growth, enhancing bone growth and / or bone strength in an infant, young child or child in need thereof, the composition comprising a low sugar, low lactose, milk-based composition comprising galactooligosaccharide (GOS).

This invention discloses a Hu sheep active peptide complex and its application in bone health care. Using healthy Hu sheep bones as raw material, collagen is extracted after defatting and decalcification. This collagen is then enzymatically hydrolyzed with trypsin and alkaline protease, followed by ultrafiltration, desalting, and freeze-drying to obtain Hu sheep bone collagen peptides. These collagen peptides are mixed with pharmaceutical excipients, calcium source compounds, chondroprotective agents, and fat-soluble vitamins. An ethanol-water binder solution containing palmitoyl aspartate diethyl ester and hesperidin-3-O-glucoside is added, and the mixture is granulated, dried, sized, and pressed to obtain the active peptide complex. This complex, through the synergistic effect of its components, can significantly promote osteoblast proliferation and inhibit apoptosis, effectively increasing bone density in osteoporosis model animals. It also exhibits excellent biocompatibility and no cytotoxicity, solving the problems of limited function, insufficient preparation efficiency, and instability of existing single active peptides. This makes it suitable for the development and application of bone health-related nutritional supplements.

The invention provides a composition for improving bone joints and promoting bone health as well as a preparation method and application thereof, and relates to the technical field of compositions. The composition is prepared from N-acetylglucosamine and a turmeric extract. The composition can improve the differentiation activity of cartilage precursor cells, effectively promote synthesis of cartilage matrixes, increase the structural construction ability of cartilage tissues, reverse expression down-regulation of cartilage synthesis markers, down-regulate abnormally high expression of cartilage decomposition markers and maintain metabolic balance of cartilage synthesis and decomposition, and has the effects of improving the cartilage tissue differentiation activity and improving the cartilage tissue differentiation activity. Abnormal high secretion of tumor necrosis factors alpha and interleukin 6 in LPS-induced cartilage cells is reduced, and the effects of resisting inflammation, resisting cartilage degradation and maintaining cartilage metabolism balance are achieved.

The present invention pertains to the use of a live Saccharomyces cerevisiae strain for the treatment and / or prevention of bone-loss disorders. The present invention further pertains to a combination of a live Saccharomyces cerevisiae strain with vitamin K2 for the treatment and / or prevention of bone- loss disorders such as osteoporosis. The present inventors have shown that such a combination allows significantly improving bone health markers while reducing negative markers associated with osteoclastogenic activity.